Challenges in Alzheimer's Drug Development

from Alzheimer's Speaks · host Lori La Bey

Today Alzheimer's Speaks Radio Host, Lori La Bey is going to talk with Dr Elliot Goldstein, with ProMIS Neurosciences about a highly awaited Phase 3 trial and the challenges in Alzheimer's drug development. Further Infomration on ProMIS Neurosciences Website: www.promisneurosciences.com Additional Resources: https://alzheimersnewstoday.com/2018/01/11/study-shows-promis-alzheimers-therapy-attacks-only-harmful-protein-in-brain/ http://www.bioworld.com/report/BWIS03052018PromisNeurosciences.pdf For Additional Resources fromAlzheimer's SpeaksSupport this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Apr 3, 2018

Embed this episode

Attribution link and audio player

What this episode covers

Dr Elliot Goldstein with ProMIS Neurosciences Talks About Alzheimer's Drug Development

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Challenges in Alzheimer's Drug Development

0:00 59:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Alzheimer's Speaks?

This episode is 59 minutes long.

When was this Alzheimer's Speaks episode published?

This episode was published on April 3, 2018.

Can I download this Alzheimer's Speaks episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!